10-K Filing

REGENERON PHARMACEUTICALS, INC. CIK: 872589 FY 2018

Filing Information

Form Type	10-K
Accession Number	`0001532176-19-000009`
Period End Date	20181231
Filing Date	20190207
Fiscal Year	2018
Fiscal Period	FY
XBRL Instance	regn-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 97 Cash Flow Statement 100 Stockholders Equity 41

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	30.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	30.00M	shares	Point-in-time
Preferred stock, issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$812.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$535.20M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.47B	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$1.34B	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$596.80M	USD	Point-in-time
Accounts receivable - trade, net	`AccountsReceivableNetCurrent`	$1.54B	USD	Point-in-time
Accounts receivable - trade, net	`AccountsReceivableNetCurrent`	$1.72B	USD	Point-in-time
Accounts receivable from Sanofi	`AccountsReceivableRelatedPartiesCurrent`	$193.70M	USD	Point-in-time
Treasury stock, outstanding (in shares)	`TreasuryStockShares`	3.99M	shares	Point-in-time
Accounts receivable from Sanofi	`AccountsReceivableRelatedPartiesCurrent`	$226.40M	USD	Point-in-time
Treasury stock, outstanding (in shares)	`TreasuryStockShares`	3.76M	shares	Point-in-time
Accounts receivable from Bayer	`AccountsAndNotesReceivableNet`	$242.00M	USD	Point-in-time
Accounts receivable from Bayer	`AccountsAndNotesReceivableNet`	$293.10M	USD	Point-in-time
Inventories	`InventoryNet`	$726.10M	USD	Point-in-time
Inventories	`InventoryNet`	$1.15B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$225.10M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$243.30M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.45B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.33B	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$1.75B	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$1.49B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$2.58B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$2.36B	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$828.70M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$506.30M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$127.40M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$77.90M	USD	Point-in-time
Total assets	`Assets`	$11.73B	USD	Point-in-time
Total assets	`Assets`	$8.76B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$178.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$218.20M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$637.20M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$772.10M	USD	Point-in-time
Deferred revenue, current	`ContractWithCustomerLiabilityCurrent`	$320.10M	USD	Point-in-time
Deferred revenue, current	`ContractWithCustomerLiabilityCurrent`	$452.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.14B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.44B	USD	Point-in-time
Capital and facility lease obligations	`Capitalandfacilityleaseobligationsnoncurrent`	$703.50M	USD	Point-in-time
Capital and facility lease obligations	`Capitalandfacilityleaseobligationsnoncurrent`	$708.50M	USD	Point-in-time
Deferred revenue, noncurrent	`ContractWithCustomerLiabilityNoncurrent`	$464.20M	USD	Point-in-time
Deferred revenue, noncurrent	`ContractWithCustomerLiabilityNoncurrent`	$629.20M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$361.70M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$152.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.98B	USD	Point-in-time
Total liabilities	`Liabilities`	$2.62B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred Stock, $.01 par value; 30,0000,000 shares authorized; issued and outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.01 par value; 30,0000,000 shares authorized; issued and outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$3.91B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$3.51B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$5.25B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.95B	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$600.00K	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-12.30M	USD	Point-in-time
Treasury Stock, at cost; 3,990,021 shares in 2018 and 3,763,868 shares in 2017	`TreasuryStockValue`	$316.20M	USD	Point-in-time
Treasury Stock, at cost; 3,990,021 shares in 2018 and 3,763,868 shares in 2017	`TreasuryStockValue`	$396.40M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.65B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.14B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$8.76B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$4.45B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$11.73B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$8.76B	USD	Point-in-time

Income Statement 97 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.86B	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.58B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$6.71B	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.93B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.32B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.61B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.47B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.51B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$5.87B	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.50B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.66B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.05B	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.08B	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.19B	USD	Annual
Selling, general, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.32B	USD	Annual
Selling, general, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.56B	USD	Annual
Selling, general, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.18B	USD	Annual
Total expenses	`CostsAndExpenses`	$3.79B	USD	Annual
Total expenses	`CostsAndExpenses`	$3.53B	USD	Annual
Total expenses	`CostsAndExpenses`	$4.18B	USD	Annual
Income from operations	`OperatingIncomeLoss`	$1.33B	USD	Annual
Income from operations	`OperatingIncomeLoss`	$2.08B	USD	Annual
Income from operations	`OperatingIncomeLoss`	$2.53B	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$6.30M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$47.30M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$24.00M	USD	Annual
Interest expense	`InterestExpense`	$25.10M	USD	Annual
Interest expense	`InterestExpense`	$28.20M	USD	Annual
Interest expense	`InterestExpense`	$7.20M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-1.10M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$19.10M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-900.00K	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.08B	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.33B	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.55B	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$434.30M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$109.10M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$880.00M	USD	Annual
Net income	`NetIncomeLoss`	$387.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$173.50M	USD	1 Quarter
Net income	`NetIncomeLoss`	$594.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$248.90M	USD	1 Quarter
Net income	`NetIncomeLoss`	$820.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$551.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$895.50M	USD	Annual
Net income	`NetIncomeLoss`	$2.44B	USD	Annual
Net income	`NetIncomeLoss`	$1.20B	USD	Annual
Net income	`NetIncomeLoss`	$478.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$388.30M	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$3.66	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$1.62	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$2.36	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$3.64	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$7.58	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$5.50	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$22.65	USD	Annual
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$5.12	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$8.55	USD	Annual
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$11.27	USD	Annual
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$4.44	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.34	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$7.15	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$10.34	USD	Annual
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$21.29	USD	Annual
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.16	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.82	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.32	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$7.70	USD	Annual
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$5.17	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.16	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.50	USD	1 Quarter
Weighted average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	106.30M	shares	Annual
Weighted average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	104.70M	shares	Annual
Weighted average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	107.90M	shares	Annual
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	114.80M	shares	Annual
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	115.90M	shares	Annual
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	116.30M	shares	Annual
Net income	`NetIncomeLoss`	$387.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$173.50M	USD	1 Quarter
Net income	`NetIncomeLoss`	$594.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$248.90M	USD	1 Quarter
Net income	`NetIncomeLoss`	$820.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$551.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$895.50M	USD	Annual
Net income	`NetIncomeLoss`	$2.44B	USD	Annual
Net income	`NetIncomeLoss`	$1.20B	USD	Annual
Net income	`NetIncomeLoss`	$478.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$388.30M	USD	1 Quarter
Unrealized (loss) gain on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-21.40M	USD	Annual
Unrealized (loss) gain on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-7.00M	USD	Annual
Unrealized (loss) gain on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$12.70M	USD	Annual
Unrealized gain on cash flow hedges	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$800.00K	USD	Annual
Unrealized gain on cash flow hedges	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$700.00K	USD	Annual
Unrealized gain on cash flow hedges	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	-	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$874.10M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$1.21B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$2.44B	USD	Annual

Cash Flow Statement 100 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$387.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$173.50M	USD	1 Quarter
Net income	`NetIncomeLoss`	$594.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$248.90M	USD	1 Quarter
Net income	`NetIncomeLoss`	$820.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$551.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$895.50M	USD	Annual
Net income	`NetIncomeLoss`	$2.44B	USD	Annual
Net income	`NetIncomeLoss`	$1.20B	USD	Annual
Net income	`NetIncomeLoss`	$478.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$388.30M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$148.20M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$104.70M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$145.50M	USD	Annual
Non-cash compensation expense	`ShareBasedCompensation`	$427.40M	USD	Annual
Non-cash compensation expense	`ShareBasedCompensation`	$507.30M	USD	Annual
Non-cash compensation expense	`ShareBasedCompensation`	$559.90M	USD	Annual
Other non-cash items, net	`OtherNoncashIncomeExpense`	$-12.10M	USD	Annual
Other non-cash items, net	`OtherNoncashIncomeExpense`	$-63.50M	USD	Annual
Other non-cash items, net	`OtherNoncashIncomeExpense`	$-45.10M	USD	Annual
Deferred taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$360.10M	USD	Annual
Deferred taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$140.00M	USD	Annual
Deferred taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-318.80M	USD	Annual
Increase in Sanofi, Bayer, and trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$143.80M	USD	Annual
Increase in Sanofi, Bayer, and trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$268.90M	USD	Annual
Increase in Sanofi, Bayer, and trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$362.70M	USD	Annual
Increase in inventories	`IncreaseDecreaseInInventories`	$149.80M	USD	Annual
Increase in inventories	`IncreaseDecreaseInInventories`	$314.20M	USD	Annual
Increase in inventories	`IncreaseDecreaseInInventories`	$387.90M	USD	Annual
(Increase) decrease in prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-36.10M	USD	Annual
(Increase) decrease in prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$55.70M	USD	Annual
(Increase) decrease in prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$113.30M	USD	Annual
(Decrease) increase in deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-194.50M	USD	Annual
(Decrease) increase in deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$244.30M	USD	Annual
(Decrease) increase in deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-113.10M	USD	Annual
Increase (decrease) in accounts payable, accrued expenses, and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-23.20M	USD	Annual
Increase (decrease) in accounts payable, accrued expenses, and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$210.00M	USD	Annual
Increase (decrease) in accounts payable, accrued expenses, and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$254.00M	USD	Annual
Total adjustments	`AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-249.30M	USD	Annual
Total adjustments	`AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$108.60M	USD	Annual
Total adjustments	`AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$590.40M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.31B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.20B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.49B	USD	Annual
Purchases of marketable and other securities	`PaymentsToAcquireMarketableSecurities`	$1.28B	USD	Annual
Purchases of marketable and other securities	`PaymentsToAcquireMarketableSecurities`	$809.40M	USD	Annual
Purchases of marketable and other securities	`PaymentsToAcquireMarketableSecurities`	$1.85B	USD	Annual
Sales or maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$775.60M	USD	Annual
Sales or maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$544.60M	USD	Annual
Sales or maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$274.50M	USD	Annual
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$511.90M	USD	Annual
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$383.10M	USD	Annual
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$272.60M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$10.00M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.46B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.01B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.05B	USD	Annual
Proceeds in connection with capital and facility lease obligations	`ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities`	$5.10M	USD	Annual
Proceeds in connection with capital and facility lease obligations	`ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities`	$57.00M	USD	Annual
Proceeds in connection with capital and facility lease obligations	`ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities`	-	USD	Annual
Payments in connection with capital and facility lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$19.90M	USD	Annual
Payments in connection with capital and facility lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$32.80M	USD	Annual
Payments in connection with capital and facility lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	-	USD	Annual
Repayments of convertible senior notes	`RepaymentsOfConvertibleDebt`	-	USD	Annual
Repayments of convertible senior notes	`RepaymentsOfConvertibleDebt`	-	USD	Annual
Repayments of convertible senior notes	`RepaymentsOfConvertibleDebt`	$12.90M	USD	Annual
Payments in connection with reduction of outstanding warrants	`PaymentsForRepurchaseOfWarrants`	$643.40M	USD	Annual
Payments in connection with reduction of outstanding warrants	`PaymentsForRepurchaseOfWarrants`	-	USD	Annual
Payments in connection with reduction of outstanding warrants	`PaymentsForRepurchaseOfWarrants`	-	USD	Annual
Proceeds from issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$114.50M	USD	Annual
Proceeds from issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$126.70M	USD	Annual
Proceeds from issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$240.20M	USD	Annual
Payments in connection with Common Stock tendered for employee tax obligations	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$301.70M	USD	Annual
Payments in connection with Common Stock tendered for employee tax obligations	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$187.20M	USD	Annual
Payments in connection with Common Stock tendered for employee tax obligations	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$143.20M	USD	Annual
Repurchases of Common Stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Repurchases of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$4.40M	USD	Annual
Repurchases of Common Stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-24.40M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-700.50M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-77.10M	USD	Annual
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$277.50M	USD	Annual
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$655.00M	USD	Annual
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-261.40M	USD	Annual
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$547.70M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.48B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$809.10M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$825.20M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$547.70M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.48B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$809.10M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$825.20M	USD	Point-in-time
Cash paid for interest (net of amounts capitalized)	`InterestPaidNet`	$18.70M	USD	Annual
Cash paid for interest (net of amounts capitalized)	`InterestPaidNet`	$5.50M	USD	Annual
Cash paid for interest (net of amounts capitalized)	`InterestPaidNet`	$22.30M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$481.40M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$205.60M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$754.80M	USD	Annual

Stockholders Equity 41 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$3.65B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$6.14B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$8.76B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$4.45B	USD	Point-in-time
Issuance of Common Stock in connection with exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$115.20M	USD	Annual
Issuance of Common Stock in connection with exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$240.60M	USD	Annual
Issuance of Common Stock in connection with exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$114.20M	USD	Annual
Common Stock tendered upon exercise of stock options and vesting of restricted stock in connection with employee tax obligations	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$187.20M	USD	Annual
Common Stock tendered upon exercise of stock options and vesting of restricted stock in connection with employee tax obligations	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$143.20M	USD	Annual
Common Stock tendered upon exercise of stock options and vesting of restricted stock in connection with employee tax obligations	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$301.70M	USD	Annual
Issuance of Common Stock in connection with conversion of convertible notes	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$48.00M	USD	Annual
Issuance of restricted stock under Long-Term Incentive Plan	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Issuance of restricted stock under Long-Term Incentive Plan	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	Annual
Issuance of Common Stock in connection with Company 401(k) Savings Plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$26.90M	USD	Annual
Issuance of Common Stock in connection with Company 401(k) Savings Plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$16.60M	USD	Annual
Issuance of Common Stock in connection with Company 401(k) Savings Plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$19.40M	USD	Annual
Stock-based compensation charges	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$524.60M	USD	Annual
Stock-based compensation charges	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$574.90M	USD	Annual
Stock-based compensation charges	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$444.80M	USD	Annual
Acquisition of Common Stock	`TreasuryStockValueAcquiredCostMethod`	$80.20M	USD	Annual
Acquisition of Common Stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	Annual
Reduction of warrants	`AdjustmentsToAdditionalPaidInCapitalOther`	$-643.30M	USD	Annual
Reduction of equity component of convertible notes	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments`	$47.80M	USD	Annual
Net income	`NetIncomeLoss`	$387.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$173.50M	USD	1 Quarter
Net income	`NetIncomeLoss`	$594.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$248.90M	USD	1 Quarter
Net income	`NetIncomeLoss`	$820.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$551.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$895.50M	USD	Annual
Net income	`NetIncomeLoss`	$2.44B	USD	Annual
Net income	`NetIncomeLoss`	$1.20B	USD	Annual
Net income	`NetIncomeLoss`	$478.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$388.30M	USD	1 Quarter
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$13.40M	USD	Annual
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-21.40M	USD	Annual
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-6.30M	USD	Annual
Ending Balance	`StockholdersEquity`	$3.65B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$6.14B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$8.76B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$4.45B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.